This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hartley, J. A. Articles by Mattes, W. B. Search for Related Content PubMed PubMed Citation Articles by Hartley, J. A. Articles by Mattes, W. B.

DNA Sequence Selectivity of Guanine-N7 Alkylation by Three Antitumor Chloroethylating Agents

Laboratory of Molecular Pharmacology, Developmental Therapeutics Program, Division of Cancer Treatment, National Cancer Institute, NIH, Bethesda, Maryland 20205

The DNA sequence selectivities of guanine-N7 alkylation produced by three chloroethylating antitumor agents, 1-(2-chloroethyl)-3-(cis-2-hydroxy) cyclohexyl-1-nitrosourea (cis-2-OH CCNU), 2-chloroethyl (methylsulfonyl)methanesulfonate, and 8-carbamoyl-3-(2-chloroethyl)imidazo-[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (mitozolomide), were examined using a modification of the Maxam and Gilbert sequencing technique. In a region of pBR322 DNA, 2-chloroethyl (methylsulfonyl)methanesulfonate produced approximately the same degree of alkylation at all guanines. cis-2-OH CCNU, however, preferentially alkylated the middle guanines in runs of three or more guanines; the intensity of the reaction increased with the number of adjacent guanines in the DNA sequence. Mitozolomide produced the same pattern of preferential alkylation but not as intensely as cis-2-OH CCNU. Three other nitrosoureas, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea, 1-(2-fluorethyl)-3-cyclohexyl-1-nitrosourea, and 1-(2-chloroethyl)-1-nitrosourea gave similar patterns of alkylation to that of cis-2-OH CCNU at pH 7.2. The ratio of 7-hydroxyethylguanine to 7-chloroethylguanine was approximately the same following treatment of the synthetic polymers dG_m·dC_m and (dG·dC)_m with cis-2-OH CCNU, indicating that 7-chloroethylation and 7-hydroxyethylation were enhanced similarly by the presence of adjacent guanines. Ethylnitrosourea produced relatively little alkylation preference. The results suggest that the alkylating intermediates, 2-chloroethyldiazohydroxide and 2-hydroxyethyldiazohydroxide, tend to react preferentially with those guanine-N7 positions the electronegativity of which is enhanced by the presence of neighboring guanines. This is consistent with the presence of cationic character in the alkylating centers of these intermediates. 2-Chloroethyl (methylsulfonyl)methanesulfonate and ethyldiazohydroxide would not be expected to have strong cationic character, in agreement with their lack of sequence selectivity.

¹ To whom requests for reprints should be addressed, at Laboratory of Molecular Pharmacology, Developmental Therapeutics Program, Division of Cancer Treatment, Building 37, Room 5A19, 9000 Rockville Pike, Bethesda, MD 20205.

Received 8/19/85. Revised 12/31/85. Accepted 1/ 2/86.

This article has been cited by other articles:

				M. E. Loghin, M. D. Prados, P. Wen, L. Junck, F. Lieberman, H. Fine, K. L. Fink, M. Metha, J. Kuhn, K. Lamborn, et al. Phase I Study of Temozolomide and Irinotecan for Recurrent Malignant Gliomas in Patients Receiving Enzyme-Inducing Antiepileptic Drugs: A North American Brain Tumor Consortium Study Clin. Cancer Res., December 1, 2007; 13(23): 7133 - 7138. [Abstract] [Full Text] [PDF]

				M. Ganguly, F. Wang, M. Kaushik, M. P. Stone, L. A. Marky, and B. Gold A study of 7-deaza-2'-deoxyguanosine 2'-deoxycytidine base pairing in DNA Nucleic Acids Res., September 25, 2007; 35(18): 6181 - 6195. [Abstract] [Full Text] [PDF]

				B. Gatto, S. Richter, S. Moro, G. Capranico, and M. Palumbo The topoisomerase II poison clerocidin alkylates non-paired guanines of DNA: implications for irreversible stimulation of DNA cleavage Nucleic Acids Res., October 15, 2001; 29(20): 4224 - 4230. [Abstract] [Full Text] [PDF]

				T. P. Spiro, L. Liu, S. Majka, J. Haaga, J. K. V. Willson, and S. L. Gerson Temozolomide: The Effect of Once- and Twice-a-Day Dosing on Tumor Tissue Levels of the DNA Repair Protein O6-Alkylguanine-DNA-Alkyltransferase Clin. Cancer Res., August 1, 2001; 7(8): 2309 - 2317. [Abstract] [Full Text] [PDF]

				S. L. Matheson, J. McNamee, and B. J. Jean-Claude Design of a Chimeric 3-Methyl-1,2,3-triazene with Mixed Receptor Tyrosine Kinase and DNA Damaging Properties: A Novel Tumor Targeting Strategy J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 832 - 840. [Abstract] [Full Text]

				W. R. Mancini, E. R. Glaze, P. L. Stetson, and H. S. Greenberg Sensitization of 1,3-bis(2-Chloroethyl)-1-nitrosourea and Cisplatin Cytotoxicity by 5-Bromo-2'-deoxyuridine in Human Glioma J. Pharmacol. Exp. Ther., June 1, 1999; 289(3): 1404 - 1409. [Abstract] [Full Text]

				A. Inga, F.-X. Chen, P. Monti, A. Aprile, P. Campomenosi, P. Menichini, L. Ottaggio, S. Viaggi, A. Abbondandolo, B. Gold, et al. N-(2-Chloroethyl)-N-nitrosourea Tethered to Lexitropsin Induces Minor Groove Lesions at the p53 cDNA That Are More Cytotoxic than Mutagenic Cancer Res., February 1, 1999; 59(3): 689 - 695. [Abstract] [Full Text] [PDF]

				S. D. Baker, M. Wirth, P. Statkevich, P. Reidenberg, K. Alton, S. E. Sartorius, M. Dugan, D. Cutler, V. Batra, L. B. Grochow, et al. Absorption, Metabolism, and Excretion of 14C-Temozolomide following Oral Administration to Patients with Advanced Cancer Clin. Cancer Res., February 1, 1999; 5(2): 309 - 317. [Abstract] [Full Text] [PDF]